Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
here
.
About Us
About hVIVO
Leadership Team
Our Companies
Key Stats
History
Services
New
Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
hMPV
Phase II-III Trials
Vaccine Phase II-III Trials
Laboratory Services
Assay Development
Field Trial Bio-logistics
Cell Based Assays
Molecular Services
Compound Efficacy & VRM
Biomarker Analysis
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Video Library
Events
Investors
New
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Article
Presentation
Scientific Paper
Factsheet
Case Study
Article Count
1 - 10 of 42 posts
Article
05 May 2021
How Human Challenge Trials Can Accelerate Vaccine Development
View Link
Article
23 Apr 2021
Rolling Reviews – a useful tool to speed up the regulatory review process
Rolling reviews have been in the media spotlight because of a global need to approve COVID-19 treatments and vaccines quickly. This article provides an overview of how rolling reviews work...
Read more
Article
05 Mar 2021
Hot Topics – Vaccine Solutions for Tropical Diseases
COVID-19, caused by the betacoronavirus SARSCoV-2, has emerged from a bat reservoir in temperate China, causing a global pandemic that has resulted in over 1.5 million deaths and 68 million...
Read more
Article
30 Jan 2021
Accelerated regulatory pathway for pandemic vaccines
Vaccines form an important part of the combat against the current COVID-19 health crisis. Getting a range of effective vaccines to the market quickly will be essential if we are...
Read more
Presentation
04 Sep 2020
ERS International Congress 2020 Presentation: Experimental Respiratory Syncytial Virus Infection in Adults 60-75 years
hVIVO's presentation during the ERS International Congress 2020 presentation about experimental RSV infection in adults 60-75 years.
Read more
Presentation
30 Sep 2019
Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
hVIVO's presentation during the ERS International Congress 2019 presentation about temporal relationships of cytokines, chemokines and cellular biomarkers during HRV infection in asthmatics.
Read more
Factsheet
27 Sep 2019
A Key Endpoint in Viral Challenge Models of Asthma Exacerbations
Human Rhinovirus (HRV) is reported to be a leading cause of up to 80% of asthma exacerbations. The viral pathway and associated immune responses represent a potential key therapeutic target...
Read more
Presentation
25 Sep 2019
Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model
hVIVO's presentation during the Options X conference in 2019 about pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model.
Read more
Factsheet
23 Sep 2019
The Human Viral Challenge Model with A/PERTH/16/2009 H3N2A systematic analysis from five clinical studies
The human viral challenge model is well established, safe and ideal to study influenza. It allows researchers to illuminate each step of the infection: baseline, peak and return to healthy....
Read more
11 Apr 2019
hVIVO is Gold Sponsor and presenter at World Vaccine Congress, Washington DC, USA April 2019
WVC 2017, 14-17 April 2019, Renaissance Washington DC Downtown Hotel, Washington DC, USA hVIVO is proud to once again be a Gold Sponsor of the World Vaccine Congress 2019, a...
Read more
Article Pagination
1
2
3
4
5
Articles Per Page
Articles Per Page
8
10
16
24
32
angle-down
meetup
chevron-down